Senthil Sundaram is the founder of Terns Pharmaceuticals. Terns Pharmaceuticals has raised $197M in total funding. Latest round: IPO.
Senthil Sundaram is the CEO and founder of Terns Pharmaceuticals, Inc., a biotechnology company established in 2017. Based in Foster City, CA, US, Terns Pharmaceuticals focuses on developing treatments for patients with chronic liver diseases. The company has raised a total of $197 million over three funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide